Addiction Professional Magazine Skip to content Skip to navigation

Medical director's refrain to patients: 'I don't want to go to your funeral'

September 21, 2018  |  Gary A. Enos, Editor
The Mountainside treatment facility in Connecticut is making early inroads with injectable buprenorphine as another option for blocking patients' opioid receptors.

Q & A: Hidden forces behind the US prescription drug epidemic

September 21, 2018  |  Jolynn Tumolo, Psych Congress Network
Psychiatrist Anna Lembke, MD, examines how myths, policies, and practices contributed to a crisis in her new book, "Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop."

Methamphetamine statistic raises concern in NSDUH

September 20, 2018  |  Gary A. Enos, Editor
An increase in past-year methamphetamine use in the 18-to-25 age group has placed the drug on federal officials' radar.

Analysis finds LGBT youth at greater risk of substance use

September 19, 2018  |  Gary A. Enos, Editor
An analysis of data from the Youth Risk Behavior Surveillance System finds that bisexual youth were most susceptible to polysubstance use.

Harm reduction strategies inconsistently applied among New York drug users

September 19, 2018  |  Gary A. Enos, Editor
New York City drug users are increasingly familiar with the ways they can reduce the risk of fatal overdose, but they often face barriers to implementing them regularly.

Less new opioid use, more treatment offer signs of hope in national survey

September 18, 2018  |  Gary A. Enos, Editor
The 2017 National Survey on Drug Use and Health offers some encouragement regarding the opioid crisis but growing concern for groups such as pregnant women and young adults.

New lab data on cocaine addiction opens door to potential treatments

September 17, 2018  |  Gary A. Enos, Editor
A rodent study that more closely approximated humans' drug use patterns adds to the evidence of the orexin system's role in cocaine addiction.

Fulcrum expands young-adult focus with acquisition of Life of Purpose

September 13, 2018  |  Gary A. Enos, Editor
Liberation Way and Life of Purpose Treatment Centers will now be joined under the umbrella of a new holding company. City Line Behavioral Healthcare.

RAND center seeks deeper dive into opioid policy effectiveness

September 12, 2018  |  Gary A. Enos, Editor
Among its efforts, the RAND Opioid Policy Tools and Information Center will explore why certain opioid-fighting strategies work well in some communities but not others.

Red flags on benzodiazepines, gabapentin in drug misuse report

September 11, 2018  |  Gary A. Enos, Editor
Quest Diagnostics' analysis of drug monitoring data finds several areas of potential concern, including for patients being treated in specialty substance use settings.


Addiction needs a rebranding, toward the positive

August 27, 2018     Rebecca Flood
The professional field and the general public need to discard negativity that keeps people from seeking treatment.

Treatment for youths must adjust to social disconnection

July 2, 2018     Rebecca Flood
A single approach will not suffice to meet the needs of a young population that is seeking a sense of belonging.

Patients dangerously see completion of residential care as the end

June 25, 2018     Michael Weiner, PhD, MCAP
The field needs to encourage a new mindset about continuing care for the chronic illness that addiction is.

New rules are causing more pain

May 21, 2018     Roland Reeves, MD
Providers and patients have not been sufficiently prepared to deal with a changing mindset about the use of prescription pain medication.